ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,116Medicare Part D Prescriptions Filled, Including Refills

Rank: 549 out of 6969

$413K Total Retail Price of All Prescriptions

Rank: 889 out of 6969

473 Patients Receiving at Least One Drug in Part D
52%Patients 65 Years and Older
97% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 473 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

13% of this provider’s 473 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 4,477 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$45 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
METOPROLOL TARTRATE 442 171 1 13
LEVOTHYROXINE SODIUM 347 134 2 5
SIMVASTATIN 286 125 3 1
OMEPRAZOLE 283 92 4 6
AMLODIPINE BESYLATE 251 158 5 4
FUROSEMIDE 240 163 6 10
LISINOPRIL 220 91 7 2
METFORMIN HCL 205 70 8 7
HYDROCODONE-ACETAMINOPHEN 181 95 S3 9 3
PANTOPRAZOLE SODIUM 180 91 10 31
ZOLPIDEM TARTRATE 142 63 11 16
WARFARIN SODIUM 138 105 12 20
FAMOTIDINE 131 80 13 37
GABAPENTIN 128 50 14 17
ATORVASTATIN CALCIUM 126 41 15 11
BENAZEPRIL HCL 114 65 16 18
NAPROXEN 110 25 17 62
TRAMADOL HCL 99 55 18 27
LEVETIRACETAM 98 15 19 128
OXYBUTYNIN CHLORIDE 97 46 20 126
BENZTROPINE MESYLATE 97 21 R 20 177
IPRATROPIUM-ALBUTEROL 91 80 22 212
CARVEDILOL 89 77 23 25
TAMSULOSIN HCL 85 51 24 23
GEMFIBROZIL 81 0 25 85
SPIRONOLACTONE 76 48 26 102
DONEPEZIL HCL 69 55 27 32
NAMENDA 66 59 28 51
QUETIAPINE FUMARATE 61 21 29 101
METOPROLOL SUCCINATE 60 0 30 22
TRAZODONE HCL 60 14 30 47
HEPARIN SODIUM 59 56 32 302
POTASSIUM CHLORIDE 58 51 33 30
FLUOXETINE HCL 58 0 33 43
CARBAMAZEPINE 57 0 35 204
DIOVAN 57 42 35 26
OXYBUTYNIN CHLORIDE ER 56 13 37 165
KLOR-CON 10 55 35 38 160
SERTRALINE HCL 54 24 39 38
CLOPIDOGREL 54 34 39 48
DIVALPROEX SODIUM 54 0 39 103
LANTUS 53 29 42 50
PHENYTOIN SODIUM EXTENDED 51 35 43 169
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 2, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.